Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 1596

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9A
Chunk 1596
---
     12,746,000  
     10%
  
    Branded revenue, net 
     116,115,000  
     58% 
     50,258,000  
     39%
  
    ImprimisRx revenue, net 
     83,499,000  
     42% 
     79,935,000  
     61%
  
    Total revenues, net 
    $199,614,000  
     100% 
    $130,193,000  
     100%

Other than IHEEZO, VEVYE, and one ImprimisRx product,
no other products accounted for more than 10% of total revenues for the periods presented.

Customer and Supplier Concentrations

Substantially all of the Company’s Branded
sales are made to third-party distributors who sell the products to pharmacies and to the end-users. There were two customers who
comprised more than 10%
of the Company’s Branded revenues for the year ended December 31, 2024 and one customer who comprised more than 10%
of the Company’s Branded revenues for the year ended December 31, 2023. There were no customers who comprised more than 10%
of ImprimisRx revenues for the years ended December 31, 2024 and 2023. As of December 31, 2024 and December 31, 2023, accounts
receivable from two customers and one customer accounted for 94%
and 80%,
respectively, of total consolidated accounts receivable.

The Company received its active pharmaceutical ingredients
from two and three main suppliers during the years ended December 31, 2024 and 2023, respectively. These suppliers collectively accounted
for 42%
and 64%
of active pharmaceutical ingredient purchases during the years ended December 31, 2024 and 2023, respectively.

NOTE
20. SUBSEQUENT EVENTS 

In February and March 2025, the Company issued 2,743
shares of common stock and received proceeds of $23,000
upon the exercise of options to purchase 2,743
shares of common stock with exercise prices between $6.85 to
$15.17
per share.

In January 2025, the Company issued 29,214 shares
of its common stock underlying RSUs held by a director that ceased providing services to the Company. The